Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab Use

Anna Kemp-Casey,Nicole L. Pratt,Emmae N. Ramsay,Elizabeth E. Roughead

Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab Use

2018

Anna Kemp-Casey
Nicole L. Pratt
Emmae N. Ramsay
Elizabeth E. Roughead

Objectives To describe how post-market utilisation analysis in Australia informs cost-effectiveness assessment and pricing decisions, using aflibercept and ranibizumab as case studies.

Keywords:

Actuarial science
Ranibizumab
Aflibercept
Medicine
Health economics
Family medicine
Cohort
Macular degeneration
Physical therapy
Clinical trial
Public health
Health administration

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations